Andrew Huberman· PhD
And if it's androgenetic alopecia or male pattern baldness, even if they're female, perhaps say PCOS, something like that, then you want some sort of strategy to decrease the activity of that androgen receptor.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And if it's androgenetic alopecia or male pattern baldness, even if they're female, perhaps say PCOS, something like that, then you want some sort of strategy to decrease the activity of that androgen receptor.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.